AMH and Ovarian cyst: During this period, 66 patients were assessed for eligibility, and six, five, two, and one patient were excluded due to low anti-Müllerian hormone (AMH) serum levels (< 0.05 ng/mL), refusal to participate, the disappearance of a unilateral ovarian cyst, and the development of bilateral ovarian cysts.